Abstract
We describe the pathogenesis and the typical clinical and laboratory features of the hyperthermia syndromes that may develop during neuroleptic drug treatment, environmental exposure or following the use of inhalational anesthetics. Since the features are similar and confusion is possible we emphasize the need for prompt diagnosis so that appropriate treatment, can be started without delay. Hyperthermic reactions have common pathophysiological mechanisms and they may be seen as an abnormal individual response to organic and functional stressors.
Sommario
Gli Autori discutono i meccanismi patogenetici e descrivono le manifestazioni cliniche ed i riscontri laboratoristici delle ipertermie che si sviluppano in seguito a trattamento con farmaci neurolettici oppure in particolari condizioni ambientali o in seguito a trattamenti anestesiologici.
La tempestività della diagnosi diventa condizione indispensabile per una corretta terapia in quanto vi sono elementi clinici assai simili, talora sovrapposti, e comunque tali da poter generare confusione. Si ritiene comunque che questi stati di ipertermia altro non sono se non una risposta che si realizza attraverso meccanismi fisiopatologici communi.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amore M., Montanari M., Vitali M.:La catatonia acuta letale. Minerva Psichiatrica 4:351–354, 1986.
Amore M., Giordani L., Montanari M.:Sindrome maligna da neurolettici: Revisione critica. Rivista Sperimentale di Freniatria 1:170–196, 1988.
Anderson R.J., Reed G., Knochel J.:Heatstroke. Adv. Intern. Med. 28:115–140, 1983.
Ayd F.J. Jr.:Fatal hyperpyrexia during chlorpromazine therapy. J. Clin. Exp. Psychopat. 17:189–192, 1956.
Belfer M.L., Shader R.I.:Autonomic effects; in: Psychotropic Drug Side Effects: Clinical and Theoretical Perspectives. Shader S.I., Di Mascio A. (eds.), Baltimore, Williams and Wilkins Co., pp. 116–123, 1970.
Caroff S.N.:The neuroleptic malignant syndrome. J. Clin. Psychiat. 41:79–83, 1980.
Caroff S.N., Rosenberg H., Gerber I.C.:Neuroleptic malignant syndrome and malignant hyperthermia. Lancet 1:244, 1983.
Clark W.G., Lipton J.M.:Drug-related heatstroke. Pharmacol. Ther. 26:345–388, 1984.
Cox B., Lee T.F.:Location of receptors mediating hypothermia after injection of dopamine agonists in rats. Br. J. Pharmacol. 59:467–468, 1977.
Delay J., Pichot P., Lampérière T. et al.:L'emploi des butyrophénones en psychiatrie: étude statistique et psychométrique. In: Symposium Internationale su Haloperidol e Triperidol, Milano, Istituto Lusofarmaco, pp. 305–319, 1962.
Denborough M.A., Lovell R.R.H.:Anaesthetic deaths in a family. Lancet 2:45, 1960.
Feibel I.H., Schiffer R.B.:Sympathodrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report. Am. J. Psychiatry 138: 1115–1116, 1981.
Haggerty J.J.Jr., Bentsen B.S., Gillette G.M.:Neuroleptic malignant syndrome superimposed on tardive dyskinesia. Br. J. Psychiatry 150: 104–105, 1987.
Hashimoto F., Sherman C.B., Jeffery W.H.:Neuroleptic malignant syndrome and dopaminergic blokade. Arch. Intern. Med. 144:629–630, 1984.
Hermesh H., Huberman M. et al.:Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors. N. Nery. Ment. Dis. 172:692–695, 1984.
Kick K.:Fieberzustande unter psychpharmakotherapie: differencial typologie un diagnostik. Pharmakopsychiatrie 14:12–20, 1981.
Knoll H.:Clinical-genealogical contribution to the problem of pernicious catatonia. Arch. fur Psychiatr. Nervenkantz. 192:1–33, 1954.
Kraepelin E.:Lectures on Clinical Psychiatry. Johnstone T. (ed), New York, William Wood, 1905.
Lew T.Y., Tollefson G.:Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biol. Psychiatry 18:1441–1446, 1983.
Samie M.R.:Neuroleptic malignant-like syndrome induced by metoclopramide. Movement Disorders 2:57–60, 1987.
Scheiddegar W.:Katatone Todesfalle in der Psychiatrischenklinik von Zurich con 199 bis 1928. Zeitschrift fur die Gesampte. Neurol. und Psychiatrie. 120:587–649, 1929.
Stauder K.H.:Die Todliche Katatonie. Archiv. fur Psychiatr. Nervenkrantz 102:614–634, 1934.
Zelman S., Guillan R.:Heatstroke in phenothiazine-treated patients: a report of three fatalities. Am. J. Psychiatry 126:1787–1790, 1970.
Wheeler A.H., Ziegler M.G. et al.:Episodic catatonia, hypertension and tachycardia: elevated plasma catecholamines. Neurology 35:1053–1055, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amore, M., Cerisoli, M. Heatstroke and hyperthermias. Ital J Neuro Sci 13, 337–341 (1992). https://doi.org/10.1007/BF02223099
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02223099